GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Neptunus Interlong Bio-Technique Co Ltd (HKSE:08329) » Definitions » Beginning Cash Position

Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Beginning Cash Position : HK$0 Mil (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Shenzhen Neptunus Interlong Bio-Technique Co Beginning Cash Position?

Shenzhen Neptunus Interlong Bio-Technique Co's Beginning Cash Position for the quarter that ended in Jun. 2024 was HK$0 Mil.

Shenzhen Neptunus Interlong Bio-Technique Co's annual Beginning Cash Position declined from Dec. 2021 (HK$504 Mil) to Dec. 2022 (HK$254 Mil) but then increased from Dec. 2022 (HK$254 Mil) to Dec. 2023 (HK$317 Mil).

Shenzhen Neptunus Interlong Bio-Technique Co Beginning Cash Position Historical Data

The historical data trend for Shenzhen Neptunus Interlong Bio-Technique Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Neptunus Interlong Bio-Technique Co Beginning Cash Position Chart

Shenzhen Neptunus Interlong Bio-Technique Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 360.06 455.46 504.34 253.66 317.30

Shenzhen Neptunus Interlong Bio-Technique Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Shenzhen Neptunus Interlong Bio-Technique Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Shenzhen Neptunus Interlong Bio-Technique Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Shenzhen Neptunus Interlong Bio-Technique Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Neptunus Interlong Bio-Technique Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Neptunus Interlong Bio-Technique Co Ltd (HKSE:08329) » Definitions » Beginning Cash Position
Comparable Companies
HKSE:01312 HKSE:00897 HKSE:01498 HKSE:00575 HKSE:00858 HKSE:01011 HKSE:01889 HKSE:08622 HKSE:00455 HKSE:03839 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA XSWX:SDZ NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
95 Queensway, 18th Floor, United Centre, Admiralty, Hong Kong, HKG
Website
https://www.interlong.com
Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sales of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines; and the Sales and distribution of medicines and healthcare products. The majority of revenue is generated from the Manufacturing and selling of medicines.

Shenzhen Neptunus Interlong Bio-Technique Co Headlines

No Headlines